PRL and neoplasm: In patients treated primarily with DA (n = 79), reduction of serum PRL to <2×ULN or reduction of the maximum tumor diameter by 20% after the first year of treatment were both associated with a combined response at the last follow-up [both univariate and multivariate (Table 3) analyses].